Latest Capital Raises News

Imugene Limited reported a significant 54% reduction in net loss for FY25, driven by cost efficiencies and promising clinical progress in its immuno-oncology pipeline. The company’s lead asset, azer-cel, achieved a 79% response rate in Phase 1b trials and secured FDA Fast Track designation.

Peninsula Energy Limited has had its ASX trading suspension lifted following the completion of a placement and institutional entitlement offer, signaling renewed market activity.

Peninsula Energy has successfully completed the first tranche of a fully underwritten A$69.9 million equity raise, securing strong institutional support including cornerstone investors Tees River and Davidson Kempner. The company now opens its retail entitlement offer to shareholders, aiming to fund the ramp-up of uranium production at its Lance Project in Wyoming.

Amplia Therapeutics has successfully raised A$2.65 million through its Share Purchase Plan, exceeding expectations and bolstering funding for pivotal clinical trials of its lead drug narmafotinib.

Propel Funeral Partners reported a 7.9% revenue increase in FY25, driven by acquisitions and modest organic growth, while maintaining strong cash flow and a solid balance sheet. The company signals continued expansion supported by favorable demographics and a leadership transition.

Bio-Gene Technology Limited reported a net loss of AUD 2.58 million for FY2025 while making significant strides in developing its bio-insecticides Flavocide and Qcide, securing US Department of Defense grants and expanding global partnerships.

Story-i Limited has agreed to acquire LIT Energy Network Australia for AUD 8 million, targeting Vietnam’s booming electric motorcycle market. The deal comes as Story-i prepares for ASX delisting and a $5 million capital raise.

Sandon Capital Investments has announced a modest increase in its annual dividend and will begin paying fully franked dividends monthly, aiming to provide shareholders with more frequent income amid a changing economic backdrop.

Aurelia Metals Limited has reported a strong turnaround with a $48.9 million net profit for FY25, driven by operational progress at its Federation Mine and the approval of the Great Cobar Project. The company’s strategic focus on base metals growth and sustainability underpins its improved financial and safety performance.

Felix Group Holdings Ltd has launched a capped $1 million Share Purchase Plan (SPP) offering eligible shareholders a discounted entry to support its strategic acquisition of Nexvia Pty Ltd and fuel growth initiatives. This retail-focused SPP complements a larger institutional placement as Felix aims to expand its enterprise software footprint.

Felix Group Holdings has launched a $1 million Share Purchase Plan offering shares at a 3.7% discount to support its acquisition of Nexvia Pty Ltd and growth initiatives.

Firebrick Pharma has closed a $1.4 million placement to fund expansion of its Nasodine nasal spray in key international markets and advance new product development.